Volume 28 - Issue 4 - April 2020
Cover Story
04/15/2020
Coronavirus disease, or COVID-19, may still be novel to the dermatology community, but research since its initial appearance in humans have elucidated some of the mystery around the virology and epidemiology of...
Coronavirus disease, or COVID-19, may still be novel to the dermatology community, but research since its initial appearance in humans have elucidated some of the mystery around the virology and epidemiology of...
...
04/15/2020
The Dermatologist
Column
Spotlight
04/14/2020
Dr Konda is an assistant clinical professor of dermatology at the University of Florida Health System where he serves as medical director and director of Mohs surgery and surgical dermatology. He completed his...
Dr Konda is an assistant clinical professor of dermatology at the University of Florida Health System where he serves as medical director and director of Mohs surgery and surgical dermatology. He completed his...
Dr...
04/14/2020
The Dermatologist
Chief Medical Editor Message
04/14/2020
Up until now, I’ve been blessed to live in the greatest time in human history. Born in the late 1950s, I lived through a period with nothing like the plagues and wars of the past. Born too late to go to Vietnam and...
Up until now, I’ve been blessed to live in the greatest time in human history. Born in the late 1950s, I lived through a period with nothing like the plagues and wars of the past. Born too late to go to Vietnam and...
Up...
04/14/2020
The Dermatologist
04/14/2020
Biologics May be Effective for Erythrodermic Psoriasis
Some biologics, such as ustekinumab (Stelara) and infliximab (Remicade), were found to be safe and effective for patients with erythrodermic psoriasis in a...
Biologics May be Effective for Erythrodermic Psoriasis
Some biologics, such as ustekinumab (Stelara) and infliximab (Remicade), were found to be safe and effective for patients with erythrodermic psoriasis in a...
...
04/14/2020
The Dermatologist
